SCHEMBL9983033

SCHEMBL9983033

O=P(c1ccccc1)(c1ccccc1)c1ccc2c(c1)c1ccccc1n2Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.60
▸ P2RX4 Q99571 2/20 0.54
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MAPT P10636 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HDAC6 Q9UBN7 2/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC10 Q969S8 1/20 0.46
▸ SRC P12931 1/20 0.45
▸ NTRK1 P04629 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19751365 0.84 CYP19A1 (0.41) CYP19A1P2RX4MEN1KMT2AMAPT
SCHEMBL23607253 0.83 PSMD14 (0.48) CYP19A1P2RX4MAPTHDAC6HDAC1
SCHEMBL22843276 0.82 NPSR1 (0.45) MEN1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL14923167 0.79 KDM4E (0.48) MEN1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL14923178 0.79 KDM4E (0.48) MEN1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL14923191 0.79 KDM4E (0.48) MEN1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL14923199 0.79 KDM4E (0.48) MEN1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL22025396 0.79 MAPT (0.47) MEN1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL14923189 0.79 KDM4E (0.48) MEN1KMT2AMAPTSMN1; SMN2KDM4E
SCHEMBL14923173 0.79 KDM4E (0.48) MEN1KMT2AMAPTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8592055-B2 Compound for organic electroluminescent device and organic electroluminescent device having the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2013-11-26 — — US disclosed
US-20110309345-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE HAVING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2011-12-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110309345-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE HAVING THE SAME ARL1, MCOLN2, NAT1 CYP19A1 1433/4885P2RX4 898/4885MEN1 813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback